UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 27.

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, T; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation, 52(4):650-652.

Kambakamba, P; Linecker, M; Alvarez, F A; Samaras, P; Reiner, C S; Raptis, D A; Kron, P; de Santibanes, E; Petrowsky, H; Clavien, P A; Lesurtel, M (2016). Short chemotherapy-free interval improves oncological outcome in patients undergoing two-stage hepatectomy for colorectal liver metastases. Annals of Surgical Oncology, 23(12):3915-3923.

Koeberle, D; Dufour, J-F; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Buehlmann, M; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer Research (SAKK) (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology, 27(5):856-861.

Fuchs, I; Gerber, B; Samaras, P (2015). Monoklonale Gammopathie in der hausärztlichen Praxis: diagnostische Abklärung und Therapie des Plasmazell-Myeloms. Praxis, 104(21):1141-1150.

Samaras, P; Pfrommer, S; Seifert, B; Petrausch, U; Mischo, A; Schmidt, A; Schanz, U; Nair, G; Bargetzi, M; Taverna, C; Stupp, R; Stenner-Liewen, F; Renner, C (2015). Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Biology of Blood and Marrow Transplantation, 21(1):74-80.

Goetti, R; Reiner, C S; Knuth, A; Klotz, E; Stenner, F; Samaras, P; Alkadhi, H (2012). Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Investigative Radiology, 47(1):18-24.

Goetti, R; Reiner, C S; Knuth, A; Klotz, E; Stenner, F; Samaras, P; Alkadhi, H (2012). Quantitative perfusion analysis of malignant liver tumors: Dynamic computed tomography and contrast-enhanced ultrasound. Investigative Radiology, 47(1):18-24.

Luehty, A; Stenner, F; Lohri, C; Muller, C; Samaras, P; Steiner, R; van den Broek, Maries; Mischo, A; Renner, C; Knuth, A; Ruegg, C; Wenger, R H; Zweifel, M (2011). Autologous Stem Cell Transplantation: Leukapheresis Product has Anti-angiogenic Effects In Vivo Correlating with Neutrophil-derived VEGFR1. Anticancer Research, 31(10):3115-3124.

Petrausch, U; Samaras, P; Mischo, A; Stenner, F; Tinguely, M; Schäfer, N; Studer, G; Renner, C (2011). Die Nachsorge beim Hodgkin-Lymphom. Praxis, 100(25):1515-1522.

Rettig, L; Seidenberg, S; Parvanova, I; Samaras, P; Knuth, A; Pascolo, S (2011). Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. International Journal of Cancer, 129(4):832-.838.

Samaras, P; Blickenstorfer, M; Siciliano, R D; Haile, S R; Buset, E M; Petrausch, U; Mischo, A; Honegger, H; Schanz, U; Stüssi, G; Stahel, R A; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Annals of Hematology, 90(1):89-94.

Mischo, A; Bubel, N; Cebon, J S; Samaras, P; Petrausch, U; Stenner-Liewen, F; Schaefer, N G; Kubuschok, B; Renner, C; Wadle, A (2011). Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis. International Journal of Oncology, 39(1):287-294.

Samaras, P; Breitenstein, S; Haile, S R; Stenner-Liewen, F; Heinrich, S; Feilchenfeldt, J; Renner, C; Knuth, A; Pestalozzi, B C; Clavien, P A (2011). Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Annals of Surgical Oncology, 18(7):1924-1931.

Zardavas, D; Meisel, A; Samaras, P; Knuth, A; Renner, C; Pestalozzi, B C; Stenner-Liewen, F (2011). Temsirolimus is highly effective as third-line treatment in chromophobe renal cell cancer. Case Reports in Oncology, 4(1):16-18.

Samaras, P; Geier, A; Riesterer, O; Dutkowski, P (2011). Tumore des biliären Trakts: Häufigkeit, Diagnostik und Therapie. Schweizer Zeitschrift für Onkologie, (2):26-31.

Samaras, P; Blickenstorfer, M; Haile, S R; Siciliano, D; Petrausch, U; Mischo, A; Zweifel, M; Honegger, H; Schanz, U; Stüssi, G; Taverna, C; Bauer, S; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Medical Weekly, 141:w13203.

Mahfud, M; Breitenstein, S; El-Badry, A M; Puhan, Milo A; Rickenbacher, A; Samaras, P; Pessaux, P; Lopez-Ben, S; Jaeck, D; Figueras, J; Alain-Clavien, P (2010). Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World Journal of Surgery, 34(1):92-100.

Petrausch, U; Samaras, P; Haile, S R; Veit-Haibach, P; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schäefer, N G (2010). Risk adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first line therapy. Annals of Oncology, 21(8):1694-1698.

Goetti, R; Leschka, S; Desbiolles, L; Klotz, E; Samaras, P; von Boehmer, L; Stenner, F; Reiner, C; Stolzmann, P; Scheffel, H; Knuth, A; Marincek, B; Alkadhi, H (2010). Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Investigative Radiology, 45(7):419-426.

Petrausch, U; Samaras, P; Veit-Haibach, P; Tschopp, A; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schaefer, N G (2010). Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of Oncology, 21(5):1053-1057.

Samaras, P; Heider, H; Haile, S R; Petrausch, U; Schaefer, N G; Siciliano, R D; Meisel, A; Mischo, A; Zweifel, M; Knuth, A; Stenner-Liewen, F; Renner, C (2010). Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP. Annals of Hematology, 89(8):783-787.

Zweifel, M; Stenner-Liewen, F; Weber, A; Samaras, P; Zaugg, K; Knuth, A; Soyka, J D (2010). Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma. Clinical Nuclear Medicine, 35(2):103-104.

Samaras, P; Buset, E M; Siciliano, R D; Haile, S R; Petrausch, U; Mischo, A; Honegger, H; Pestalozzi, B C; Schanz, U; Stüssi, G; Stahel, R A; Knuth, A; Renner, C; Stenner-Liewen, F (2010). Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation. Oncology, 79(1-2):93-97.

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Stenner, F; Liewen, H; Zweifel, M; Weber, A; Tchinda, J; Bode, B; Samaras, P; Bauer, S; Knuth, A; Renner, C (2008). Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo. Cancer Science, 99(9):1847-1852.

Samaras, P; Pfammatter, T; Pestalozzi, B C (2008). Hemorrhage associated with hepatic artery pseudoaneurysms after regional chemotherapy with floxuridine: case report. International Seminars in Surgical Oncology, 5:17:1-5.

Samaras, P; Dold, S; Braun, J; Kestenholz, P; Breitenstein, S; Imhof, A; Renner, C; Stenner-Liewen, F; Pestalozzi, B C (2008). Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology, 74(3-4):237-244.

This list was generated on Mon Jul 24 05:11:10 2017 CEST.